Related Experiment Video
Updated: Oct 12, 2025

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
Sara Nava1, Daniela Lisini1, Simona Frigerio1
1Cell Therapy Production Unit, Neurology Unit, UCV, Neurological Institute "C. Besta" IRCCS Foundation, Via Celoria 11, 20133 Milan, Italy.
Dendritic cell (DC) vaccines show established safety and antitumor response capabilities in cancer patients. Combining DC immunotherapy with chemotherapy and radiotherapy may enhance treatment efficacy beyond monotherapy.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Dendritic cells (DCs) are crucial immune cells for initiating antigen-specific immune responses.
- DCs can be engineered ex vivo as cancer vaccines by stimulating them with inflammatory molecules and tumor antigens.
- Existing research confirms the safety and antitumor potential of DC vaccination in select cancer patients.
Purpose of the Study:
- To review the integration of dendritic cell (DC) vaccination with multimodality cancer therapy.
- To explore the potential of combining DC-based immunotherapy with chemotherapy and radiotherapy for improved cancer treatment paradigms.
Main Methods:
- Review of existing scientific literature on dendritic cell vaccination and cancer immunotherapy.
- Analysis of data from clinical trials investigating DC-based vaccines in combination therapies.
- Synthesis of findings to address the role of DC vaccination in multimodality cancer treatment.
Main Results:
- Dendritic cell vaccination is safe and can induce antitumor immune responses.
- Monotherapy with DC vaccines has shown limited survival benefits in some cancer patients.
- Combining DC immunotherapy with chemotherapy and radiotherapy is hypothesized to improve treatment efficacy.
Conclusions:
- Dendritic cell vaccination is a promising immunotherapy approach for cancer treatment.
- The optimal role for DC vaccines may be in combination with conventional therapies like chemotherapy and radiotherapy.
- Further research is warranted to optimize combinatorial strategies for enhanced cancer treatment outcomes.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
The Tumor Microenvironment
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

